person

Birte Glenthoj, MD, DMSc.

Birte Glenthoj, MD, DMScBirte Glenthøj, MD, DMSc
as of 2026-07-01
Monitor thisAsk about this
at a glance
Roles: Principal Investigator, Study Director
KOL signal score 5
0 publications · 0 high-value
Synthesized from structured facts only — each point cited above.

Profile

Affiliation
Center for Neuropsychiatric Schizophrenia Research, University of Copenhagen, Psychiatric Center Glostrup Glostrup, Denmark
Roles
Principal Investigator, Study Director
KOL signal
5
Publications
0 (0 high-value)
Trial investigator
yes

Trials led

5
Dopaminergic, Functional, Structural, and Cognitive Disturbances in First-episode Schizophrenia
NCT00206960—Completed
Optimization of Treatment and Management of Schizophrenia in Europe (OPTIMISE): Substudy Site Copenhagen
NCT01555814—Completed
Neurobiological and Neurocognitive Disturbances in First-episode Schizophrenia
NCT00207064—Completed
The CAMPUS Project: Cholinergic Augmentation of Cognitive Deficits in Schizophrenia
NCT00206947Phase 2Terminated
Will Decreased Noradrenergic Activity Normalize Information Processing in Patients With Schizophrenia?
NCT00206986—Completed

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
STUDY_DIRECTOR
Dopaminergic, Functional, Structural, and Cognitive Disturbances in First-episode Schizophrenia
trial
Neurobiological and Neurocognitive Disturbances in First-episode Schizophrenia
trial
The CAMPUS Project: Cholinergic Augmentation of Cognitive Deficits in Schizophrenia
trial
Will Decreased Noradrenergic Activity Normalize Information Processing in Patients With Schizophrenia?
trial
PRINCIPAL_INVESTIGATOR
Optimization of Treatment and Management of Schizophrenia in Europe (OPTIMISE): Substudy Site Copenhagen
trial